安控科技(300370.SZ):保證人俞凌與被保證人創益產業投資簽訂框架協議意向金之保證協議
格隆匯 9 月 22日丨安控科技(300370.SZ)公佈,宜賓市敍州區創益產業投資有限公司(“創益產業投資”)、公司和公司控股股東俞凌於2020年9月5日簽署了《合作框架協議》,協議約定了引進上市公司、上市公司主體遷址、股權收購、產業投資等內容,其中在引進上市公司的相關內容中,約定在公司辦理完有效抵、質押及擔保手續後,創益產業投資於抵押、質押和擔保手續辦理完成後3個工作日內向安控科技指定的銀行賬户支付1.5億元意向金。
為確保《合作框架協議》的有效履行,保證人俞凌與被保證人創益產業投資經平等協商,於近日簽訂了《框架協議意向金之保證協議》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.